Lorazepam

劳拉西泮

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameLorazepam
Drug Alias Name氯羟去甲安定LorazepamumLora氯拉西泮氯羟安定 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety DisordersAnxiety +[13] 
Global Approved IndicationsAnxiety DisordersAnxietyDepression +[6] 
Approved Indications in ChinaAnxietySleep Initiation and Maintenance Disorders
Original Approved Country/TerritoryBelgium
Original Approved Date1970/01/01
Country/TerritoryBelgiumUnited StatesIndia +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesHikma Pharmaceuticals Usa IncBausch Health Us LlcPfizer Japan Inc +[6] 
Inactive CompaniesUniversity Of Pittsburgh PhysiciansEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentMylan Pharmaceuticals Inc +[10] 
Active IndicationsDepressive Disorder, MajorAnxiety DisordersAnxiety +[9] 
Inactive IndicationsSubstance-Related DisordersAcute PainSeizures +[4] 

Other Information

ATC CodeN05BA06
Related LinksWikipediaDrugBankKEGG